MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors

Although chimeric antigen receptor T cell (CAR-T) is a promising immunotherapy in hematological malignancies, there remain many obstacles to CAR-T cell therapy for solid tumors. Identifying appropriate tumor-associated antigens (TAAs) is especially critical for success. Using a bioinformatics approa...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Wen, Kang, Ju-Seop, Oh, Sukjoong, Tu, Ang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122994/
https://www.ncbi.nlm.nih.gov/pubmed/37078298
http://dx.doi.org/10.4196/kjpp.2023.27.3.241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122994/
https://www.ncbi.nlm.nih.gov/pubmed/37078298
http://dx.doi.org/10.4196/kjpp.2023.27.3.241

Ejemplares similares